Skip to main content
. Author manuscript; available in PMC: 2013 Dec 3.
Published in final edited form as: Physiol Rep. 2013 Jul 8;1(2):e00023. doi: 10.1002/phy2.23

Figure 2.

Figure 2

Mean (±SE) plasma glucose A) in response to early (n=5) and late insulin infusions (n=5), B) in response to low (LDG; n=3) and high dose (HDG; n=4) glucagon-like peptide-1 (GLP-1) infusions plasma (GLP-1), and C) the resulting glucose clearance rates (K) in response to the exogenous infusions. # denotes significantly (p<0.05) different from early fasting; * denotes significantly (p<0.05) different from baseline (T0); + denotes significantly (p<0.05) different from late fasting GTT; ‡ denotes significantly (p<0.05) different from LDG. Late GTT glucose, and early and late glucose clearance values adapted from (32).